Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists

Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists

US Patent 10183940 · Granted Jan 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use2025
Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitors2025
Imidazopyrazine derivatives and the use thereof as medicament2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as2024
Phenyltetrazole derivatives as plasma kallikrein inhibitors2024
Substituted 3-phenoxyazetidin-1-yl-pyrazines2023
CCR2 receptor antagonists and uses thereof2023
CCR2 receptor antagonists and uses thereof2023